[Treatment of systemic lupus and other collagenoses with antilymphocyte globulins. Apropos of 10 cases].
D000328:Adult; D000799:Angioedema / Q000209:etiology; D000906:Antibodies / Q000032:analysis; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D003095:Collagen Diseases / Q000628:therapy*; D004844:Epistaxis / Q000209:etiology; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007108:Immune Tolerance; D005779:Immunodiffusion; D008180:Lupus Erythematosus, Systemic / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011379:Prognosis
D000906:Antibodies; D000961:Antilymphocyte Serum; D005938:Glucocorticoids; D001379:Azathioprine
Traitement du lupus systémique et autres collagénoses par les globulines anti-lymphocytaires. A propos de 10 observations.